HealthTree Foundation

💚 Your voice matters in CLL research! Have CLL/SLL? Share your treatment experiences and preferences in HealthTree's 10–12-minute survey, in collaboration with PeerView Health. Take the survey: healthtree.org/cll/surveys/w… #CLL #CLLResearch

Transfusions can affect much more than time at the clinic. Have MDS, CMML, or an MDS precursor condition? Share your experience in HealthTree's 14-minute survey, in collaboration with Dr. Elizabeth Griffiths of Roswell Park. Take part: healthtree.org/leukemia+lymp… #MDS #CMML

Why have plasma cell leukemia patients been underrepresented in clinical trials? Dr. Douglas Sborov joins the HealthTree Podcast to discuss PCL research and the QUANTUM trial. 🎧 Listen to the full episode: healthtree.org/leukemia+lymp… #PCL #MyelomaResearch

No one should have to navigate blood cancer alone. 💚 The HealthTree Coach Program connects patients & caregivers with trained volunteers who understand the journey. Need support? Find a Coach. Want to help? Become one. Your story can make a difference. 🔗 healthtree.org/myeloma/news/… #HealthTree #BloodCancer

Don't miss this live CLL CME on Nov. 17, 5–6 PM CT! @ParadigmMedCom Join Dr. William G. Wierda to explore treatment strategies and shared decision-making in personalized CLL care. activities.paradigmmc.com/14… @CllSociety @ParadigmMedCom #CLL #CME

Mindfulness can be a powerful tool during cancer treatment. 💚 Watch Dr. Linda Carlson share practical, evidence-based techniques to manage anxiety, fatigue, and pain. 🎥 Watch the recording: healthtree.org/blood-cancer/… #CancerSupport #Mindfulness

Does everyone with multiple myeloma need a stem cell transplant? New research is exploring more personalized treatment approaches. Plus, HealthTree patient data reveals what a transplant is really like. Explore the findings: healthtree.org/cll+dlbcl+fol… #MultipleMyeloma

The CAR-T landscape in lymphoma is evolving fast. Join Drs. Sairah Ahmed (@drsairahahmed), Sunita Nasta, and Nirav Shah (@niravshahmd) at this @PeerView symposium in New Orleans during #ASH26, 12/11 at 7:30 AM CST: bit.ly/2026-CART-T #Lymphoma

Thank you to our esteemed #OHSU hosts and @fredhutch speakers at the HealthTree Portland Roundtable including Dr, Rebecca Silbermann, Dr. Eva Medvedova, Dr. Andy Chen, Jacqueline Trussell, AGACNP-BC, and Dr. Richa Thakur. Amazing day supporting #myeloma patients and answering critical questions. We are so grateful! #mmsm

Amazing presentation about maximizing #myeloma QOL with Jacqueline Trussell, AGACNP-BC of #OHSU at the HealthTree Portland Roundtable. #mmsm

Sequencing for relapsed/refractory #myeloma is key. Rotate drugs, space out BCMA directed therapies, preserve T cell fitness with earlier collection and avoiding bendamustine, and switching drug targets when BCMA fails are working strategies. Dr. Richa Thakur at the HealthTree Portland Roundtable. #mmsm

There are four new drug classes in #myeloma care for relapsed/refractory disease. Taking advantage of these immunotherapies is critical for both community and academic center patients. Dr. Richa Thakur shares details at the HealthTree Portland Roundtable. #mmsm

Managing bone health and side effects need to be managed by communicating well with your care team. Staying active can help improve your life regardless of therapy according to Dr. Rebecca Silbermann at the HealthTree Portland Roundtable. #mmsm #OHSU

MRD testing can help patients know how and when to pick their second #myeloma therapy and personalize care. Dr. Rebecca Silbermann shares NDMM strategies and MRD at the HealthTree Portland Roundtable. #mmsm

CAR T, transplant or bispecifics for #myeloma care? Dr. Andy Chen weighs the options at the HealthTree Portland Roundtable. #mmsm

Astounding growth in CAR T cell therapy in #myeloma. Thank you #OHSU and Dr. Andy Chen for your great work helping patients access new therapies. HealthTree Roundtable in Portland #mmsm

Amyloidosis can happen along with #myeloma. If you have shortness of breath, leg swelling, weight loss, neuropathy, foamy urine or lowered blood pressure, ask your doc to check. Dr. Eva Medvedova at the HealthTree Portland Roundtable #mmsm

The approval of daratumumab has opened the door to a wave of clinical trials for HRSMM. Dr. Eva Medvedova at the HealthTree Portland Roundtable. #mmsm